Please Wait.....
Report
Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market By Device Type (Stents, Accessories), By Application (Portal hypertension, Budd Chiari Syndrome, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-10-01 I 206 Pages I Allied Market Research
The global transjugular intrahepatic portosystemic shunt (TIPS) market was valued at $93,370.5 thousand in 2021, and is projected to reach $127,937.57 thousand by 2031, registering a CAGR of 3.2% from 2022 to 2031.
Transjugular intrahepatic portosystemic shunt (TIPS) is an artificial passage that allows fluid to move from one part of the liver to another. It connects veins that carry blood from gastrointestinal tract and intra-abdominal organs to liver and veins from liver to right part of the heart. In this procedure a small metal device, which is called stent is placed to keep connection of vein and liver. Doctor inserts a catheter, which is a flexible tube through skin into the vein of neck. This vein is known as jugular vein. Transjugular intrahepatic portosystemic shunt reduces internal bleeding in stomach and may also reduce accumulation of fluid in the abdomen. This procedure is done by interventional radiologists using x-ray guidance.
Growth of the transjugular intrahepatic portosystemic shunt market is supported by rise in cases of portal hypertension and increase in adoption of transjugular intrahepatic portosystemic shunts to minimize barriers. In addition, constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) make individuals more susceptible to liver failure. In addition, a number of factors such as a large number of technological advancements in transjugular intrahepatic portosystemic shunt and rise in emphasis on early intervention and primary prevention of liver related disorders are responsible for driving the market growth. Moreover, rise in demand and adoption of products such as stent, catheters, sheath and guidewires and launch of transjugular intrahepatic portosystemic shunt devices by large number of key players are the major factors driving the market growth. Furthermore, according to the World Health Organization, in 2019, approximately 1.28 billion people suffered from hypertension, which is the main cause of death. Thus, rise in number of cases of people suffering from hypertension leads to increase in use of transjugular intrahepatic portosystemic shunt drives growth of the market. Moreover, surge in incidences of emergency surgeries and growing adoption of vascular devices propel growth of the transjugular intrahepatic portosystemic shunt (TIPS) market. Liver disease causes damage of liver and leads to cirrhosis.
According to the report by the Gov.UK in 2021, it was estimated that there were approximately 10,127 deaths due to liver disease in England and it increased as compared to 2019. Moreover, the number of rate of people died in England due to liver disease was 20.6 per 100,000 population with ages under 75. In addition, according to the National Center for Disease Control and Prevention in 2020, it was estimated that mortality rate of cirrhosis was 7.0% in New York, with approximately 1,672 number of deaths. Thus, rising number of cases suffering from cirrhosis led to increase in usage of transjugular intrahepatic portosystemic shunt devices for treatment that significantly drive growth of the market. For instance, in 2019, it was estimated that approximately 820,000 people died due to cirrhosis and hepatocellular carcinoma globally. Thus, rising number of cases of cirrhosis leads to higher demand among people. Hence, usage of transjugular intrahepatic portosystemic shunt (TIPS) fuel the growth of the market. Moreover, development of medical device industries and improvement in healthcare spending are anticipated to drive growth of the transjugular intrahepatic portosystemic shunt (TIPS) market.?
For instance, in June 2022, Boston Scientific Corporation entered into definitive agreement with Synergy Innovation Co. Ltd. to purchase its majority stake of M.I. Tech Co., Ltd., Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I Tech Co. Ltd is the creator of the HANAROSTENT technology, a non-vascular self-expanding metal stent. Non-vascular gastrointestinal stents are used to help treat occlusions in various areas of gastrointestinal tract. Thus, rising number of strategies such as agreement and acquisitions among key players drive growth of the market.
Furthermore, rise in geriatric population and increase in burden of liver diseases lead to rise in awareness regarding transjugular intrahepatic portosystemic shunt treatment among people, which drive growth of the market. Moreover, according to the American Liver foundation in 2020, it was estimated that approximately 51,642 adults in the U.S died due to liver disease and 4.5 million adults have been diagnosed with the disease. Moreover, The American Liver Foundation is the largest non-profit organization focused solely on promoting liver health and disease prevention.
The American Liver Foundation fights against liver disease by funding scientific research and support programs for patients with liver disease and their families as well as creating public awareness by launching various awareness campaigns about liver wellness and disease prevention. Thus, rising number of cases of liver diseases in the U.S and other countries and initiatives taken by private and government healthcare organizations to prevent liver disorders drive growth of the global market. Moreover, increase in healthcare expenditure in emerging economies and high demand for minimally invasive procedures are expected to provide new opportunities for market players. However, lack of awareness in developing regions is anticipated to hamper the market growth.
The transjugular intrahepatic portosystemic shunt (TIPS) market is studied by device type, which is divided into stents and accessories and by application, which is fragmented into portal hypertension, Budd-Chiari Syndrome, and others. By end user, it is categorized into hospitals, specialty clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The key players mentioned in the report are Boston Scientific Corporation, W.L Gore Associated Ltd, Angiodynamics, and Neuromedex GmbH, and Cook Medical, Becton Dickinson and Company, and Terumo Medical Corporation.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transjugular intrahepatic portosystemic shunt (tips) market analysis from 2021 to 2031 to identify the prevailing transjugular intrahepatic portosystemic shunt (tips) market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the transjugular intrahepatic portosystemic shunt (tips) market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global transjugular intrahepatic portosystemic shunt (tips) market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
- Hospitals
- Specialty Clinics
- Others
By Device Type
- Stents
- Accessories
By Application
- Portal hypertension
- Budd Chiari Syndrome
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
- Key Market Players
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Cook
- BD
- AngioDynamics Inc.
- Neuromedex GmbH
- Terumo Medical Corporation
- Company 8
- Company 9
- Company 10
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Stents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Accessories
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Portal hypertension
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Budd Chiari Syndrome
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Specialty Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Device Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Device Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Device Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Device Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Device Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Device Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Device Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Device Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Device Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Device Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Device Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Device Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Device Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Device Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Device Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Device Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Device Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Device Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Device Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Device Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Device Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Device Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Device Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Boston Scientific Corporation
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 W. L. Gore & Associates, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cook
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 BD
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 AngioDynamics Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Neuromedex GmbH
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Terumo Medical Corporation
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Company 8
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Company 9
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Company 10
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 2. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR STENTS, BY REGION, 2021-2031 ($THOUSAND)
TABLE 3. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR STENTS, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 4. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR ACCESSORIES, BY REGION, 2021-2031 ($THOUSAND)
TABLE 5. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 6. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 7. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR PORTAL HYPERTENSION, BY REGION, 2021-2031 ($THOUSAND)
TABLE 8. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR PORTAL HYPERTENSION, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 9. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR BUDD CHIARI SYNDROME, BY REGION, 2021-2031 ($THOUSAND)
TABLE 10. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR BUDD CHIARI SYNDROME, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 11. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR OTHERS, BY REGION, 2021-2031 ($THOUSAND)
TABLE 12. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 14. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($THOUSAND)
TABLE 15. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 16. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR SPECIALTY CLINICS, BY REGION, 2021-2031 ($THOUSAND)
TABLE 17. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 18. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, FOR OTHERS, BY REGION, 2021-2031 ($THOUSAND)
TABLE 19. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 20. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY REGION, 2021-2031 ($THOUSAND)
TABLE 21. NORTH AMERICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 22. NORTH AMERICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 23. NORTH AMERICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 24. NORTH AMERICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 25. U.S. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 26. U.S. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 27. U.S. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 28. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 29. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 30. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 31. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 32. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 33. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 34. EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 35. EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 36. EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 37. EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 38. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 39. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 40. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 41. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 42. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 43. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 44. UK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 45. UK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 46. UK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 47. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 48. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 49. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 50. SPAIN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 51. SPAIN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 52. SPAIN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 53. REST OF EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 54. REST OF EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 55. REST OF EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 56. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 57. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 58. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 59. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 60. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 61. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 62. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 63. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 64. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 65. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 66. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 67. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 68. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 69. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 70. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 71. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 72. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 73. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 74. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 75. REST OF ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 76. REST OF ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 77. REST OF ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 78. LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 79. LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 80. LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 81. LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY COUNTRY, 2021-2031 ($THOUSAND)
TABLE 82. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 83. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 84. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 85. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 86. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 87. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 88. SOUTH AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 89. SOUTH AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 90. SOUTH AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 91. REST OF LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY DEVICE TYPE, 2021-2031 ($THOUSAND)
TABLE 92. REST OF LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY APPLICATION, 2021-2031 ($THOUSAND)
TABLE 93. REST OF LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET, BY END USER, 2021-2031 ($THOUSAND)
TABLE 94.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 95.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 96.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 97.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 98.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 99.W. L. GORE & ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 100.W. L. GORE & ASSOCIATES, INC.: OPERATING SEGMENTS
TABLE 101.W. L. GORE & ASSOCIATES, INC.: PRODUCT PORTFOLIO
TABLE 102.W. L. GORE & ASSOCIATES, INC.: NET SALES,
TABLE 103.W. L. GORE & ASSOCIATES, INC.: KEY STRATERGIES
TABLE 104.COOK: COMPANY SNAPSHOT
TABLE 105.COOK: OPERATING SEGMENTS
TABLE 106.COOK: PRODUCT PORTFOLIO
TABLE 107.COOK: NET SALES,
TABLE 108.COOK: KEY STRATERGIES
TABLE 109.BD: COMPANY SNAPSHOT
TABLE 110.BD: OPERATING SEGMENTS
TABLE 111.BD: PRODUCT PORTFOLIO
TABLE 112.BD: NET SALES,
TABLE 113.BD: KEY STRATERGIES
TABLE 114.ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 115.ANGIODYNAMICS INC.: OPERATING SEGMENTS
TABLE 116.ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 117.ANGIODYNAMICS INC.: NET SALES,
TABLE 118.ANGIODYNAMICS INC.: KEY STRATERGIES
TABLE 119.NEUROMEDEX GMBH: COMPANY SNAPSHOT
TABLE 120.NEUROMEDEX GMBH: OPERATING SEGMENTS
TABLE 121.NEUROMEDEX GMBH: PRODUCT PORTFOLIO
TABLE 122.NEUROMEDEX GMBH: NET SALES,
TABLE 123.NEUROMEDEX GMBH: KEY STRATERGIES
TABLE 124.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 125.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 126.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 127.TERUMO MEDICAL CORPORATION: NET SALES,
TABLE 128.TERUMO MEDICAL CORPORATION: KEY STRATERGIES
TABLE 129.COMPANY 8: COMPANY SNAPSHOT
TABLE 130.COMPANY 8: OPERATING SEGMENTS
TABLE 131.COMPANY 8: PRODUCT PORTFOLIO
TABLE 132.COMPANY 8: NET SALES,
TABLE 133.COMPANY 8: KEY STRATERGIES
TABLE 134.COMPANY 9: COMPANY SNAPSHOT
TABLE 135.COMPANY 9: OPERATING SEGMENTS
TABLE 136.COMPANY 9: PRODUCT PORTFOLIO
TABLE 137.COMPANY 9: NET SALES,
TABLE 138.COMPANY 9: KEY STRATERGIES
TABLE 139.COMPANY 10: COMPANY SNAPSHOT
TABLE 140.COMPANY 10: OPERATING SEGMENTS
TABLE 141.COMPANY 10: PRODUCT PORTFOLIO
TABLE 142.COMPANY 10: NET SALES,
TABLE 143.COMPANY 10: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET SEGMENTATION
FIGURE 2.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031
FIGURE 3.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,BY DEVICE TYPE,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF STENTS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 15.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,BY APPLICATION,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PORTAL HYPERTENSION TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF BUDD CHIARI SYNDROME TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 19.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,BY END USER,2021(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031(%)
FIGURE 23.TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET BY REGION,2021
FIGURE 24.U.S. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 25.CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 26.MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 27.GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 28.FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 29.UK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 30.ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 31.SPAIN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 32.REST OF EUROPE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 33.JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 34.CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 35.AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 36.INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 37.SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 38.REST OF ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 39.BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 40.SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 41.SOUTH AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 42.REST OF LAMEA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) MARKET,2021-2031($THOUSAND)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47.COMPETITIVE DASHBOARD
FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($THOUSAND)
FIGURE 50.W. L. GORE & ASSOCIATES, INC..: NET SALES ,($THOUSAND)
FIGURE 51.COOK.: NET SALES ,($THOUSAND)
FIGURE 52.BD.: NET SALES ,($THOUSAND)
FIGURE 53.ANGIODYNAMICS INC..: NET SALES ,($THOUSAND)
FIGURE 54.NEUROMEDEX GMBH.: NET SALES ,($THOUSAND)
FIGURE 55.TERUMO MEDICAL CORPORATION.: NET SALES ,($THOUSAND)
FIGURE 56.COMPANY 8.: NET SALES ,($THOUSAND)
FIGURE 57.COMPANY 9.: NET SALES ,($THOUSAND)
FIGURE 58.COMPANY 10.: NET SALES ,($THOUSAND)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security